Akihisa Matsuda Selected Research

milk fat globule

3/2013	Milk fat globule--EGF factor VIII ameliorates liver injury after hepatic ischemia-reperfusion.
7/2012	Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2.
1/2012	Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses.
11/2011	Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation.
9/2011	Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.
1/2011	Milk fat globule-EGF factor VIII in sepsis and ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akihisa Matsuda Research Topics

Disease

31	Neoplasms (Cancer) 06/2022 - 03/2006
27	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 03/2006
11	Neoplasm Metastasis (Metastasis) 05/2022 - 03/2006
10	Sepsis (Septicemia) 11/2018 - 10/2005
6	Esophageal Neoplasms (Esophageal Cancer) 10/2017 - 10/2008
6	Infections 01/2016 - 05/2007
5	Inflammation (Inflammations) 06/2014 - 02/2003
4	Colonic Neoplasms (Colon Cancer) 07/2022 - 06/2015
4	Hemorrhage 02/2022 - 05/2018
4	Stomach Neoplasms (Stomach Cancer) 04/2021 - 02/2008
4	Rectal Neoplasms (Rectal Cancer) 01/2021 - 08/2018
4	Pain (Aches) 01/2020 - 02/2016
4	Critical Illness (Critically Ill) 11/2018 - 01/2011
4	Adenocarcinoma 04/2018 - 08/2006
4	Ischemia 05/2014 - 01/2011
3	Disease Progression 01/2022 - 07/2012
3	Postoperative Pain 01/2020 - 01/2016
3	Hypersensitivity (Allergy) 05/2018 - 02/2016
3	Ascites 07/2016 - 07/2008
3	Body Weight (Weight, Body) 05/2014 - 10/2005
3	Acute Lung Injury 05/2014 - 07/2012
3	Reperfusion Injury 01/2012 - 01/2011
3	Carcinoma (Carcinomatosis) 07/2009 - 01/2009
2	Lymphatic Metastasis 06/2022 - 03/2006
2	Anorexia 05/2022 - 07/2008
2	Melanoma (Melanoma, Malignant) 01/2022 - 04/2015
2	Brain Neoplasms (Brain Tumor) 08/2020 - 04/2018
2	Anastomotic Leak 01/2020 - 06/2015
2	Circulating Neoplastic Cells 11/2019 - 01/2019
2	Endometriosis 01/2019 - 11/2008
2	Pathologic Constriction (Stenosis) 08/2018 - 06/2015
2	Hernia (Hernias) 05/2018 - 01/2016
2	Inguinal Hernia (Direct Inguinal Hernia) 05/2018 - 01/2016
2	Septic Shock (Toxic Shock Syndrome) 01/2018 - 01/2018
2	Edema (Dropsy) 01/2016 - 02/2003
2	Necrosis 01/2015 - 01/2011
2	Lung Injury 06/2014 - 05/2014
2	Neoplasm Micrometastasis 02/2009 - 02/2007
1	Sigmoid Neoplasms 05/2022
1	Type IV Ehlers-Danlos Syndrome 02/2022

Drug/Important Bio-Agent (IBA)

7	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 10/2008
6	Bevacizumab (Avastin)FDA Link 05/2022 - 09/2020
6	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 12/2009
6	Cell-Free Nucleic AcidsIBA 01/2021 - 07/2016
6	Factor VIII (Coagulation Factor VIII)IBA 03/2013 - 01/2011
6	milk fat globuleIBA 03/2013 - 01/2011
6	Epidermal Growth Factor (EGF)IBA 03/2013 - 01/2011
4	Biological ProductsIBA 01/2022 - 08/2006
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2019
4	Analgesics (Analgesic Drugs)IBA 01/2020 - 02/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2016
3	trifluridine tipiracil drug combinationIBA 06/2021 - 08/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2016
3	RNA (Ribonucleic Acid)IBA 01/2019 - 04/2006
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2006
3	Docetaxel (Taxotere)FDA Link 04/2018 - 05/2009
3	Pregabalin (Lyrica)FDA Link 01/2018 - 02/2016
3	Pioglitazone (Actos)FDA Link 01/2017 - 12/2011
3	CytokinesIBA 05/2014 - 01/2012
3	Messenger RNA (mRNA)IBA 09/2011 - 10/2005
2	Carcinoembryonic AntigenIBA 11/2021 - 07/2016
2	Circulating Tumor DNAIBA 01/2021 - 01/2019
2	Leucovorin (Folinic Acid)FDA Link 01/2021 - 09/2020
2	C-Reactive ProteinIBA 01/2021 - 12/2009
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2020 - 07/2008
2	Capecitabine (Xeloda)FDA Link 09/2020 - 12/2019
2	SynaptophysinIBA 12/2019 - 08/2006
2	Chromogranin AIBA 12/2019 - 08/2006
2	LipidsIBA 01/2019 - 03/2013
2	tetra-4-amidinophenoxypropane (TAPP)IBA 05/2018 - 01/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 09/2016
2	Opioid Analgesics (Opioids)IBA 01/2018 - 09/2016
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 09/2016 - 02/2016
2	nedaplatinIBA 07/2009 - 05/2009
1	IntegrinsIBA 07/2022
1	Collagen Type III (Type III Collagen)IBA 02/2022

Therapy/Procedure

17	Therapeutics 05/2022 - 07/2008
12	Drug Therapy (Chemotherapy) 06/2022 - 07/2008
5	Lymph Node Excision (Lymph Node Dissection) 06/2022 - 07/2008
5	Esophagectomy 08/2020 - 10/2008
5	Ligation 01/2017 - 10/2005
4	Radiotherapy 06/2022 - 10/2008
4	Chemoradiotherapy 12/2019 - 10/2008
4	Critical Care (Surgical Intensive Care) 01/2018 - 01/2011
4	Punctures 01/2017 - 10/2005
3	Gastrectomy 04/2021 - 02/2008
3	Neoadjuvant Therapy 01/2021 - 10/2016
3	Laparotomy 10/2019 - 10/2009
3	Herniorrhaphy 05/2018 - 01/2016
3	Conservative Treatment 01/2015 - 12/2006
2	Colectomy 05/2022 - 03/2009
2	Surgical Instruments (Clip) 04/2021 - 01/2016
2	Length of Stay 04/2020 - 10/2016
2	Proctectomy 12/2019 - 04/2015
2	Stents 01/2019 - 10/2009
2	Adjuvant Chemotherapy 04/2018 - 07/2008
2	Intraperitoneal Injections 05/2014 - 01/2011
2	Combination Drug Therapy (Combination Chemotherapy) 07/2009 - 05/2009
1	Drug Tapering 05/2022
1	Negative-Pressure Wound Therapy 02/2022